These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 39072037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
    Crockett RA, Wilkins KB, Aditham S, Brontë-Stewart HM.
    Neurobiol Dis; 2023 Sep; 185():106243. PubMed ID: 37524210
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Altered Functional Connectivity of the Basal Nucleus of Meynert in Subjective Cognitive Impairment, Early Mild Cognitive Impairment, and Late Mild Cognitive Impairment.
    Xu W, Rao J, Song Y, Chen S, Xue C, Hu G, Lin X, Chen J.
    Front Aging Neurosci; 2021 Sep; 13():671351. PubMed ID: 34248603
    [Abstract] [Full Text] [Related]

  • 6. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Schumacher J, Ray NJ, Hamilton CA, Donaghy PC, Firbank M, Roberts G, Allan L, Durcan R, Barnett N, O'Brien JT, Taylor JP, Thomas AJ.
    Brain; 2022 Jun 03; 145(5):1773-1784. PubMed ID: 34605858
    [Abstract] [Full Text] [Related]

  • 7. Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.
    Qiu T, Hong H, Zeng Q, Luo X, Wang X, Xu X, Xie F, Li X, Li K, Huang P, Dai S, Zhang M, Alzheimer's Disease Neuroimaging Initiative.
    Neurobiol Aging; 2023 Dec 03; 132():198-208. PubMed ID: 37852044
    [Abstract] [Full Text] [Related]

  • 8. Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of Meynert integrity in amnestic Alzheimer's disease, suspected-LATE and frontotemporal dementia.
    Lagarde J, Olivieri P, Tonietto M, Noiray C, Lehericy S, Valabrègue R, Caillé F, Gervais P, Moussion M, Bottlaender M, Sarazin M.
    Alzheimers Res Ther; 2024 May 03; 16(1):97. PubMed ID: 38702802
    [Abstract] [Full Text] [Related]

  • 9. In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies.
    Schumacher J, Taylor JP, Hamilton CA, Firbank M, Cromarty RA, Donaghy PC, Roberts G, Allan L, Lloyd J, Durcan R, Barnett N, O'Brien JT, Thomas AJ.
    Neuroimage Clin; 2021 May 03; 30():102604. PubMed ID: 33711623
    [Abstract] [Full Text] [Related]

  • 10. Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment.
    Rong S, Li Y, Li B, Nie K, Zhang P, Cai T, Mei M, Wang L, Zhang Y.
    Quant Imaging Med Surg; 2021 Apr 03; 11(4):1554-1566. PubMed ID: 33816191
    [Abstract] [Full Text] [Related]

  • 11. Loss of synaptic density in nucleus basalis of meynert indicates distinct neurodegeneration in Alzheimer's disease: the RJNB-D study.
    Li B, Chen H, Zheng Y, Xu X, You Z, Huang Q, Huang Y, Guan Y, Zhao J, Liu J, Xie F, Wang J, Xu W, Zhang J, Deng Y.
    Eur J Nucl Med Mol Imaging; 2024 Dec 03; 52(1):134-144. PubMed ID: 39112615
    [Abstract] [Full Text] [Related]

  • 12. Atrophy of the cholinergic regions advances from early to late mild cognitive impairment.
    Lai YL, Hsu FT, Yeh SY, Kuo YT, Lin HH, Lin YC, Kuo LW, Chen CY, Liu HS, Alzheimer’s Disease Neuroimaging Initiative.
    Neuroradiology; 2024 Apr 03; 66(4):543-556. PubMed ID: 38240769
    [Abstract] [Full Text] [Related]

  • 13. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology.
    Nazmuddin M, van Dalen JW, Borra RJH, Stormezand GN, van der Horn HJ, van der Zee S, Boertien J, van Laar T.
    Parkinsonism Relat Disord; 2021 Dec 03; 93():43-49. PubMed ID: 34784526
    [Abstract] [Full Text] [Related]

  • 14. The structural MRI markers and cognitive decline in prodromal Alzheimer's disease: a 2-year longitudinal study.
    Wei H, Kong M, Zhang C, Guan L, Ba M, for Alzheimer’s Disease Neuroimaging Initiative*.
    Quant Imaging Med Surg; 2018 Nov 03; 8(10):1004-1019. PubMed ID: 30598878
    [Abstract] [Full Text] [Related]

  • 15. Effect of cerebral small vessel disease on the integrity of cholinergic system in mild cognitive impairment patients: a longitudinal study.
    Qiu T, Hong H, Zeng Q, Xu X, Wang Y, Zhu L, Zhang L, Li K, Dai S, Li X, Xie F, Zhang Y, Luo X, Alzheimer’s Disease Neuroimaging Initiative.
    J Neurol; 2024 May 03; 271(5):2704-2715. PubMed ID: 38381177
    [Abstract] [Full Text] [Related]

  • 16. Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
    Shafiee N, Fonov V, Dadar M, Spreng RN, Collins DL.
    Neurobiol Aging; 2024 Jul 03; 139():54-63. PubMed ID: 38608458
    [Abstract] [Full Text] [Related]

  • 17. Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson's Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy.
    Rogozinski S, Klietz M, Respondek G, Oertel WH, Grothe MJ, Pereira JB, Höglinger GU.
    Front Aging Neurosci; 2022 Jul 03; 14():851788. PubMed ID: 35431891
    [Abstract] [Full Text] [Related]

  • 18. Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert.
    van Dalen JW, Caan MWA, van Gool WA, Richard E.
    Brain Imaging Behav; 2017 Dec 03; 11(6):1707-1719. PubMed ID: 27787708
    [Abstract] [Full Text] [Related]

  • 19. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert.
    Nemy M, Cedres N, Grothe MJ, Muehlboeck JS, Lindberg O, Nedelska Z, Stepankova O, Vyslouzilova L, Eriksdotter M, Barroso J, Teipel S, Westman E, Ferreira D.
    Neuroimage; 2020 May 01; 211():116607. PubMed ID: 32035186
    [Abstract] [Full Text] [Related]

  • 20. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
    Mahady L, Nadeem M, Malek-Ahmadi M, Chen K, Perez SE, Mufson EJ.
    Neuropathol Appl Neurobiol; 2019 Jun 01; 45(4):380-397. PubMed ID: 30252960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.